GlassScriptPhysician profile
Shahab Moossavi
NPI 1730314261
$36,161.20
in general payments reported to CMS, 2019-2025
16 companies · $24K in 2025
The $24K reported for 2025 was more than what 93% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,706 · 2020: $339 · 2021: $416 · 2022: $5,986 · 2023: $3,025 · 2024: $665 · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $11K · Food and Beverage: $3,013 · Travel and Lodging: $1,612 · Entertainment: $23.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,387.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $10,678.75 |
| Food and Beverage | $3,012.59 |
| Travel and Lodging | $1,611.81 |
| Entertainment | $23.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $14,012.48 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abbott Laboratories | $12,034.23 | 2019-2025 | Mitraclip, Diamondback Coronary, Triclip |
| Cardiovascular Systems INC. | $8,361.55 | 2021-2023 | Diamondback Coronary |
| Abiomed | $891.56 | 2019-2025 | Impella |
| Boston Scientific Corporation | $236.32 | 2019-2025 | Rotapro, Ingevity+ |
| Chiesi USA, INC. | $213.03 | 2019-2022 | |
| Shockwave Medical, INC | $78.44 | 2021 | |
| Philips North America LLC | $58.96 | 2020 | |
| Opsens INC. | $55.22 | 2019-2023 | Optowire |
| Janssen Pharmaceuticals, INC | $45.82 | 2022 | |
| Haemonetics Corporation | $38.59 | 2023 | Teg6s Hemostasis System |
| Bard Peripheral Vascular, INC. | $37.03 | 2020-2021 | |
| Terumo Medical Corporation | $31.89 | 2025 | Metacross Otw, Heartrail |
| Cardiva Medical, INC. | $28.46 | 2021-2022 | |
| Biotronik INC. | $23.73 | 2019-2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ossur Americas, INC. | $13.89 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shahab Moossavi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.